SIG
43
3
KR
34
-3
QRVO
6
2
NWL
44
-4
MRK
22
3
C
58
-2
HD
47
-5
DHR
35
3
JNJ
41
2
DHI
48
3
IP
70
2
SRE
63
-3
MAS
51
4
PNW
66
3
KMX
58
3
HRL
39
15
STI
47
-12
UHS
54
3
ROK
55
8
MRO
55
3
SIG
43
3
KR
34
-3
QRVO
6
2
NWL
44
-4
MRK
22
3
C
58
-2
HD
47
-5
DHR
35
3
JNJ
41
2
DHI
48
3
IP
70
2
SRE
63
-3
MAS
51
4
PNW
66
3
KMX
58
3
HRL
39
15
STI
47
-12
UHS
54
3
ROK
55
8
MRO
55
3
Financhill
Back

Embecta Vs. Perspective Therapeutics Industry Stock Comparison

Buy
51

EMBC
Embecta

Last Price:
13.80
Seasonality Move:
-7.26%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.25
Seasonality Move:
40.67%
Buy
51
Embecta (EMBC) is a Buy

Is Embecta a Buy, Sell or Hold?

  • The current Embecta [EMBC] share price is $13.61. The Score for EMBC is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • EMBC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $6.17. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EMBC Stock Price Chart

What is Embecta's stock price today?

  • The Embecta share price today is $13.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EMBC is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $6.17
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.

EMBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: 119745 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.79 - 15.29) Sell
Bollinger Bands (100): (13.19 - 15.63) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.47 Sell
Relative Strength Index (14 RSI): 14.63 Sell
Chaikin Money Flow: -723713 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.98 - 12.88) Sell
Bollinger Bands (100): (10.81 - 14.53) Sell

EMBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.74 Sell
20-day SMA: 14.69 Sell
50-day SMA: 14.5 Sell
200-day SMA: 13.65 Sell
8-day EMA: 14.41 Sell
20-day EMA: 14.56 Sell
50-day EMA: 14.48 Sell
200-day EMA: 14.78 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.55 Sell
20-day SMA: 10.54 Sell
50-day SMA: 12.08 Sell
200-day SMA: 12.78 Sell
8-day EMA: 8.2 Sell
20-day EMA: 9.96 Sell
50-day EMA: 11.52 Sell
200-day EMA: 11.52 Sell

Embecta Earnings Growth & EMBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.12 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Embecta Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):